Unibest
← Back to patent-cliff list

CAS 814-68-6

acryloyl chloride2-Propenoyl chlorideAcryloyl chloride2-Propenoyl chloride; Acrylic acid chloride; Acrylic chloride; Acryloyl chloride

Codes: OSIM-010, IBRT-008, (IX)461018-2-a, (IV)461018-6-a, (IX)461018-8-a, (XI)461018-10-a, (X)461018-11-a, (VII)461018-17-a, (X)461018-20-a, (IV)461018-21-a, (XI)461018-25-a, (XII)461018-28-a +8 more

Application context (from source-drug indications)

Non-small cell lung cancerOsimertinib MesylateWaldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinibNon-small cell lung cancerOlmutinibHIV infectionDarunavir Ethanolate/RitonavirHIV infectionDarunavir Ethanolate/CobicistatHIV infectionDarunavir EthanolateNon-small cell lung cancerFulzerasibColorectal cancerFulzerasibSolid tumourFulzerasibNon-small cell lung cancerLazertinib MesylateHepatic function declineLazertinib MesylateMarginal zone B-cell lymphomaOrelabrutinibMantle cell lymphomaOrelabrutinibChronic lymphocytic leukaemiaOrelabrutinibImmune thrombocytopenic purpuraOrelabrutinibSystemic lupus erythematosusOrelabrutinibMultiple sclerosisOrelabrutinib

Source drugs (routes using this intermediate)

DrugTierExpiry
Osimertinib MesylateTier A — Act now2031
IbrutinibTier A — Act now2027
OlmutinibTier C — Watch / trade-
Darunavir Ethanolate/RitonavirTier C — Watch / trade-
Darunavir Ethanolate/CobicistatTier C — Watch / trade-
Darunavir EthanolateTier B — Position early-
FulzerasibTier C — Watch / trade-
Lazertinib MesylateTier C — Watch / trade-
OrelabrutinibTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

IbrutinibOptimised routesteps: 5total yield: /
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine→Di-tert-butyl [3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-2-imidodicarbonate→(3S)-1-Benzylpiperidin-3-ol→Di-tert-butyl [1-[(3R)-1-benzylpiperidin-3-yl]-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-2-imidodicarbonate→4,5,6,7-Tetrahydro-1H-indole→Di-tert-butyl [3-(4-phenoxyphenyl)-1-[(3R)-piperidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-2-imidodicarbonate→2-Propenoyl chloride→Di-tert-butyl [3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H-pyrazolo[3,4-d]pyrimidin-4-yl]-2-imidodicarbonate→Di-tert-butyl hydrazine-1,2-dicarboxylate→N'-(4,5,6,7-Tetrahydro-1H-indole-1-carbonyl)-4,5,6,7-tetrahydro-1H-indole-1-carbohydrazide
FulzerasibOptimised routesteps: 4total yield: /
tert-Butyl (4aR)-11-chloro-10-(2-fluoro-6-methoxyphenyl)-6-methyl-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-5,7-dioxo-1,2,4,4a,5,6,7,8-octahydro-3H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-3-carboxylate→(4aR)-11-Chloro-10-(2-fluoro-6-methoxyphenyl)-6-methyl-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-2,3,4,4a,6,8-hexahydro-1H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione→2-Propenoyl chloride→(4aR)-11-Chloro-10-(2-fluoro-6-methoxyphenyl)-6-methyl-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-3-(prop-2-enoyl)-2,3,4,4a,6,8-hexahydro-1H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione
FulzerasibOptimised routesteps: 9total yield: /
(aR)-6,7-Dichloro-4-hydroxy-1-(2-isopropyl-4-methyl-3-pyridyl)-1,8-naphthyridin-2-one→6,7-Dichloro-4-hydroxy-1-(2-isopropyl-4-methyl-3-pyridyl)-1,8-naphthyridin-2-one→(R)-Piperazine-1,3-dicarboxylic acid 1-tert-butyl 3-methyl diester→(aR)-6,7-Dichloro-4-hydroxy-1-(2-isopropyl-4-methyl-3-pyridyl)-3-nitro-1,8-naphthyridin-2-one→(aR)-6,7-Dichloro-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-3-nitro-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl trifluoromethanesulfonate→(aR)-1-tert-Butyl 3-methyl (3R)-4-[6,7-dichloro-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-3-nitro-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl]piperazine-1,3-dicarboxylate→(aR)-tert-Butyl (4aR)-10,11-dichloro-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-5,7-dioxo-1,2,4,4a,5,6,7,8-octahydro-3H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-3-carboxylate→Dimethoxysulfone→(aR)-tert-Butyl (4aR)-10,11-dichloro-6-methyl-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-5,7-dioxo-1,2,4,4a,5,6,7,8-octahydro-3H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-3-carboxylate→(2-Fluoro-6-hydroxyphenyl)boronic acid→(aR)-tert-Butyl (4aR)-11-chloro-10-(2-fluoro-6-hydroxyphenyl)-6-methyl-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-5,7-dioxo-1,2,4,4a,5,6,7,8-octahydro-3H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-3-carboxylate→(aR)-(4aR)-11-Chloro-10-(2-fluoro-6-hydroxyphenyl)-6-methyl-8-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-2,3,4,4a,6,8-hexahydro-1H-pyrazino[1',2':4,5]pyrazino[2,3-c][1,8]naphthyridine-5,7-dione→2-Propenoyl chloride
Lazertinib MesylateOriginator routesteps: 5total yield: /

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Unibest Nantong cGMP Site3-phenyl-1H-pyrazole-4-carbaldehyde
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site4-Chloro-2-(methylsulfonyl)pyrimidine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works4-chloro-N-(2-methoxy-4-morpholino-5-nitrophenyl)pyrimidin-2-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site1-(2-((2-methoxy-4-morpholino-5-nitrophenyl)amino)pyrimidin-4-yl)-3-phenyl-1H-pyrazole-4-carbaldehyde
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-N-(2-methoxy-4-morpholino-5-nitrophenyl)pyrimidin-2-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API WorksN1-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)-6-methoxy-4-morpholinobenzene-1,3-diamine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site4-fluoro-2-Methoxy-5-nitroaniline
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site3-(2-chloropyriMidin-4-yl)-1-Methylindole
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API WorksN-(4-fluoro-2-Methoxy-5-nitrophenyl)-4-(1-Methylindol-3-yl)pyriMidin-2-aMine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site1,4-BenzenediaMine, N1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]-2-nitro-
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like SiteN1-[2-(diMethylaMino)ethyl]-5-Methoxy-N1-Methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyriMidinyl]benzene-1,2,4-triamine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API WorksN,N,N'-Trimethylethylenediamine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site4-Methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like SiteN-(3-Chloropropyl)morpholine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works5-hydroxy-4-methoxy-2-nitrobenzoic acid ethyl ester
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.